Table 1.
Unilateral RAI (n = 18) |
Bilateral RAI (n = 19) |
|||
---|---|---|---|---|
Baseline | Follow-up | Baseline | Follow-up | |
RAI, n (%) | ||||
Unilateral | 18 (100) | 9 (50) | 0 (0) | 3 (16) |
Bilateral | 0 (0) | 1 (6) | 19 (100) | 10 (53) |
Normal | N/A | 7 (39) | N/A | 3 (16) |
No data | N/A | 1 (6) | N/A | 3 (16) |
Renal parameters, n (%) | ||||
HT | 11 (61) | 10 (56) | 16 (84) | 15 (79) |
eGFR, median (IQR) | 94 (86–107) | 101.5 (85–107) | 98 (73–135) | 104 (89–124) |
GFR <60 ml/min/1.73 m2, n (%) | 1 (6) | 1 (6) | 2 (11) | 2 (11) |
Renal asymmetry, n (%) | 5 (28) | 5 (28) | 5 (26) | 5 (26) |
Non-renal parameters, median (IQR) | ||||
ITAS2010 | 13 (9–15) | 3 (0–6) | 12 (9–14) | 1 (0.5–5.5) |
ESR | 43 (32–55) | 16 (10–24) | 59 (36–101) | 13 (8–27) |
CRP | 29 (9–45) | 4.5 (2–20) | 28 (13–65) | 3.2 (1–6) |
VDI | N/A | 4.5 (3–5) | N/A | 4 (3–7) |
HT: hypertension; VDI: Vasculitis Damage Index.